ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Sage Therapeutics Inc

Sage Therapeutics Inc (SAGE)

7.27
-0.23
(-3.07%)
Closed 11 March 7:00AM
7.25
-0.02
(-0.28%)
After Hours: 8:46AM

Sage Therapeutics Inc Financial Summary

The current SAGE market cap is 445.74M. The company's latest EPS is USD -6.5169 and P/E is -1.12.

Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 77.97M7.9M8.65M11.87M12.82M
Operating Income -42.07M-117.68M-111.3M-101.2M-102.19M
Net Income -32.71M-108.48M-102.85M-93.55M-95.78M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.11B6.31M7.69M86.46M41.24M
Operating Income 596.23M-460.91M-546.99M-579.85M-432.37M
Net Income 606.07M-457.89M-532.78M-541.49M-400.67M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 882.28M767.6M697.11M622.43M547.22M
Total Liabilities 82.75M61.8M69.04M70.6M82.13M
Total Equity 799.53M705.8M628.06M551.84M465.09M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 2.16B1.83B1.36B882.28M547.22M
Total Liabilities 86.91M96.26M103.85M82.75M82.13M
Total Equity 2.07B1.73B1.25B799.53M465.09M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -540.59M-37.83M-118.27M-200.63M-267.19M
Investing 442.91M139.44M139.05M220.1M266.68M
Financing 6.03M1.56M9.63M10.67M10.66M
Year End 31 December 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating 664.28M-378.18M-460.04M-540.59M-267.19M
Investing 442.68M-1B325.43M442.91M266.68M
Financing 426.76M13.33M3.07M6.03M10.66M
Market Cap 445.74M
Price to Earnings Ratio -1.12
Price to Sales Ratio 10.84
Price to Cash Ratio 5.52
Price to Book Ratio 0.96
Dividend Yield -

Share Statistics

Shares Outstanding 61.48M
Average Volume (1 week) 1.49M
Average Volume (1 Month) 1.58M
52 Week Change -66.73%
52 Week High 22.18
52 Week Low 4.62
Spread (Intraday) 0.15 (2.07%)

Company Info

Company Name Sage Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.sagerx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock